Skip to content
Back to Home

Speciale Invest news

Speciale Invest appears in 7 stories we have published between August 2026 and November 2026, mostly in our Technology and Business coverage. It is most often reported alongside IAN Alpha Fund, Peptris Technologies and Tenacity Ventures.

Latest development

Venomics AI raises $2.7M to hunt for drugs in animal venoms

Bengaluru startup Venomics AI has secured $2.7 million in pre-seed funding to turn animal venoms into medicines. Speciale Invest and South Park Commons co-led the round, which will expand its Venom Atlas dataset and boost its AI and lab tools for drug discovery.

6 November 2026

Covered alongside

Venomics AI raises $2.7M to hunt for drugs in animal venoms

Bengaluru biotech Venomics AI secures $2.7 million in pre-seed funding to build Venom Atlas, a dataset mapping venom molecules for new medicines.

Nov 6, 2026

Indian Startups See Marginal VC Funding Rise in Week Ending August 28

Venture capital funding into Indian startups saw a marginal rise in the week ending August 28, 2026, driven by deals in coffee brands, aerospace, and electric vehicles.

Aug 29, 2026

VyomIC raises $1.6M to build low Earth orbit satellite constellation for high-precision navigation

VyomIC secures $1.6M pre-seed funding to develop a low Earth orbit satellite constellation for high-precision positioning, navigation, and timing.

Aug 25, 2026

e-TRNL Energy raises ₹27.4 crore to scale battery cell architecture redesign

Bengaluru-based e-TRNL Energy raises ₹27.4 crore to commercialise its chemistry-agnostic battery cell architecture, aiming for faster charging, lower heat…

Aug 21, 2026

Peptris uses AI to accelerate preclinical drug discovery in Bengaluru

Peptris Technologies uses AI and machine learning to accelerate preclinical drug discovery for oncology, inflammation, and rare diseases in India.

Aug 9, 2026

Peptris Technologies secures ₹70 crore Series A for AI-led preclinical drug discovery

Peptris Technologies secures ₹70 crore in Series A funding to advance AI-led preclinical drug discovery. Lead asset PEPR-124 licensed to Revio Therapeutics.

Aug 9, 2026

India's ePlane Company Unveils eVTOL Prototype: A Leap Towards Urban Air Mobility

Discover how India's ePlane Company is pioneering urban air mobility with its eVTOL prototype, the e200X, and strategic partnerships for a Made-in-India electric air taxi.

Aug 9, 2026

Contact us

Have a story tip, correction or partnership idea?

Write to us at tarun.kumar@blogy.in or talk to the founder directly. We read every message.

Contact us